Epilepsy and antiepileptic drugs: risk factors for atherosclerosis

References

• Varley J, O'Connor R, Delanty N, et al. Towards the development of integrated epilepsy services: an audit of documented epilepsy care. Ir Med J 2011;104(7):214–7.
   PubMedGoogle Scholar
• Fitzsimons M, Normand C, Varley J, Delanty N. Evidence-based models of care for people with epilepsy. Epilepsy Behav 2012;23(1):1–6.
   PubMed Web of Science ®Google Scholar
• LaRoche SM, Helmers SL. Epilepsy in the elderly. Neurologist 2003;9(5):241–9.
   PubMed Web of Science ®Google Scholar
• Hsieh CY, Lai EC, Yang YH, Lin SJ. Comparative stroke risk of antiepileptic drugs in patients with epilepsy. Epilepsia 2013;54(1):172–80.
   PubMed Web of Science ®Google Scholar
• Olesen JB, Abildstrøm SZ, Erdal J, et al. Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study. Pharmacoepidemiol Drug Saf 2011;20(9):964–71.
   PubMed Web of Science ®Google Scholar
• Tan TY, Lu CH, Chuang HY, et al. Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia. 2009;50(6):1579–86.
   PubMed Web of Science ®Google Scholar
• Mintzer S. Metabolic consequences of antiepileptic drugs. Curr Opin Neurol 2010;23(2):164–9.
   PubMed Web of Science ®Google Scholar
• Mintzer S, Skidmore CT, Abidin CJ, et al. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol 2009;65(4):448–56.
   PubMed Web of Science ®Google Scholar
• Mintzer S, Skidmore CT, Rankin SJ, et al. Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein. Epilepsy Res 2012;98(1): 88–93.
   PubMed Web of Science ®Google Scholar
• Chuang YC, Chuang HY, Lin TK, et al. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia 2012;53(1):120–8.
   PubMed Web of Science ®Google Scholar
• Keenan N, Sadlier LG, Wiltshire E. Vascular function and risk factors in children with epilepsy: Associations with sodium valproate and carbamazepine. Epilepsy Res 2014;108(6):1087–94.
   PubMed Web of Science ®Google Scholar
• Yiş U, Doğan M. Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children. Brain Dev 2012;34(3):185–8.
   PubMed Web of Science ®Google Scholar
• Sankhyan N, Gulati S, Hari S, et al. Noninvasive screening for preclinical atherosclerosis in children on phenytoin or carbamazepine monotherapy: a cross sectional study. Epilepsy Res 2013;107(1–2):121–6.
   PubMed Web of Science ®Google Scholar
• Abd Allah F, Baligh E, Ibrahim M. Clinical relevance of carotid atherosclerosis among Egyptians: a 5-year retrospective analysis of 4,733 subjects. Neuroepidemiology 2010;35(4):275–9.
   PubMed Web of Science ®Google Scholar
• Moustafa RR, Moneim AA, Salem HH, et al. Intracranial steno-occlusive arterial disease and its associations in Egyptian ischemic stroke patients. Stroke 2013;44(2):538–41.
   PubMed Web of Science ®Google Scholar
• Ridker PM. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003;108(12):e81–5.
   PubMedGoogle Scholar
• Kamath S, Lip GY. Fibrinogen: biochemistry, epidemiology and determinants. QJM 2003;96(10):711–29.
   PubMed Web of Science ®Google Scholar
• Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369(9566):1000–15.
   PubMed Web of Science ®Google Scholar
• Kenyon K, Mintzer S, Nei M. Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsy. Seizure 2014;23(3):234–6.
   PubMed Web of Science ®Google Scholar
• Mehrpour M, Shojaie M, Zamani B, et al. Atherogenic consequence of antiepileptic drugs: a study of intima-media thickness. Neurol Sci 2014;35(2):253–7.
   PubMed Web of Science ®Google Scholar
• Gür M, Sahin DY, Elbasan Z, et al. Uric acid and high sensitive C-reactive protein are associated with subclinical thoracic aortic atherosclerosis. J Cardiol 2013;61(2):144–8.
   PubMed Web of Science ®Google Scholar
• Boos CJ, Lip GY. Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension? J Hum Hypertens 2005;19(7):511–3.
   PubMed Web of Science ®Google Scholar
• Martínez-Vila E, Páramo JA, Beloqui O, et al. Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects. Cerebrovasc Dis 2003;16(4):356–62.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Basciani F, Domizio S, et al. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr Neurol 1998;19(5):364–7.
   PubMed Web of Science ®Google Scholar
• Sözüer DT, Atakil D, Dogu O, et al. Serum lipids in epileptic children treated with carbamazepine and valproate. Eur J Pediatr 1997;156(7):565–7.
   PubMed Web of Science ®Google Scholar
• Norata GD, Catapano AL. Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag 2005;1(2):119–29.
   PubMedGoogle Scholar
• Kontush A, Chapman MJ. High-density lipoproteins : structure, metabolism, function, and therapeutics. Hoboken, N.J.: John Wiley & Sons, Inc.; 2012.
   Google Scholar
• G HB, Rao VS, Kakkar VV. Friend turns foe: transformation of anti-inflammatory HDL to proinflammatory HDL during acute-phase response. Cholesterol 2011;2011:274629.
   Google Scholar
• Mahmoudian T, Iranpour R, Messri N. Serum lipid levels during carbamazepine therapy in epileptic children. Epilepsy Behav 2005;6(2):257–9.
   PubMed Web of Science ®Google Scholar
• Desideri G, De Simone M, Iughetti L, et al. Early activation of vascular endothelial cells and platelets in obese children. J Clin Endocrinol Metab 2005;90(6):3145–52.
   PubMed Web of Science ®Google Scholar